TrialEuropean journal of heart failure2022

The impact of comorbidities on selexipag treatment effect in patients with pulmonary arterial hypertension: insights from the GRIPHON study.

Stephan Rosenkranz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.